A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01)
Patent
CA 2735263
The present invention provides an agent for inhibiting alveolar airspace enlargement containing adiponectin or an agent for inhibiting alveolar wall destruction containing adiponectin. The pulmonary disease therapeutic agents of the present invention are highly safe drugs that possess an excellent effect of decreasing the deterioration of the pulmonary function, such as airflow limitation, and exhibit an extremely high effect of treating pulmonary disease accompanied by irreversible deterioration in pulmonary function, with fewer adverse side effects such as nausea, vomiting and gastric acid secretion.
L'invention concerne un agent destiné à inhiber l'agrandissement de l'espace aérien alvéolé contenant l'adiponectine ou un agent destiné à inhiber la destruction de la paroi alvéolée contenant l'adiponectine. Les agents thérapeutiques de la maladie pulmonaire selon l'invention sont des médicaments particulièrement sûrs qui ont un excellent effet réducteur de la détérioration de la fonction pulmonaire, par exemple la limitation du débit de l'air, ainsi qu'un effet extrêmement élevé en matière de traitement de maladie pulmonaire associée à une détérioration irréversible de la fonction pulmonaire, avec peu d'effets secondaires tels que nausée, vomissement et sécrétion d'acides gastriques.
Karasutani Keiko
Kirima Kazuyoshi
Kotosai Kounori
Ohmoto Yasukazu
Yabuuchi Yoichi
Marks & Clerk
Otsuka Pharmaceutical Co. Ltd.
LandOfFree
Adiponectin for treating pulmonary disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adiponectin for treating pulmonary disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adiponectin for treating pulmonary disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1709053